MARKET

AGEN

AGEN

Agenus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.125
-0.235
-5.39%
Opening 15:08 11/21 EST
OPEN
4.350
PREV CLOSE
4.360
HIGH
4.419
LOW
4.065
VOLUME
1.37M
TURNOVER
--
52 WEEK HIGH
4.570
52 WEEK LOW
1.950
MARKET CAP
566.62M
P/E (TTM)
-4.2070
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AGEN News

  • Is the Options Market Predicting a Spike in Agenus (AGEN) Stock?
  • Zacks.1d ago
  • The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data
  • Benzinga.1d ago
  • Agenus On A Roll With More Catalysts Ahead
  • Seeking Alpha - Article.1d ago
  • B. Riley FBR Reinstates Buy on Agenus, Announces $6 Price Target
  • Benzinga.2d ago

More

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
+0.29%

Hot Stocks

Name
Price
%Change

About AGEN

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.
More

Webull offers Agenus Inc (AGEN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.